Intranasal Insulin for Treatment of Alcohol Use Disorder
Key facts
- Who runs it
- Brown University
- Where
- Providence, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 1/2
- People taking part
- 40 people, planned
- Started
- 25 Feb 2025
- Expected to end
- 31 Jan 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Regular Human Insulin then Placebo
- Placebo then Regular Human Insulin
- Record updated
- 30 September 2026
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (2)Hide the full registry criteria
Who can take part
- ≥21 years; meet any DSM-5 criteria score for AUD; Individuals who, in the last month, have consumed at least the same amount of alcohol that will be administered in the laboratory procedure (i.e. to reach BrAC levels of 0.08g/dl, ~two drinks in one occasion); BrAC=0.00g/dL at each visit; good health as confirmed by medical history, physical examination and lab tests; willing to adhere to the study procedures; understand informed consent and questionnaires in English at an 8th grade level; willing to have glucose monitored by finger stick during the laboratory procedures
Who cannot take part
- • female identifying who are breastfeeding or pregnant (assessed by a urine screen); individuals with diabetes; history of suicide attempts in the last three years; current diagnosis of other substance use disorder (other than nicotine or cannabis); use of drugs (e.g. stimulants/opioids) at each alcohol administration session (by urine tox screen); cannabis intoxication (by clinical assessments); use of medications that may interact with insulin and alcohol (by Micromedex database); hypersensitivity to insulin; any nasal disease/congestion that may interfere with intranasal drug absorption; baseline hypoglycemia (blood glucose ≤65mg/dL) or hyperglycemia (blood glucose >200mg/dL) (by finger stick)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Alcohol use disorder
This trial is currently available in United States.
- Brown UniversityProvidence, United StatesContact: Zoe BrownTaking people
About the trial
What the trial wants to find out
This is a randomized controlled trial (RCT), within-subject, crossover, double-blind, placebo-controlled in non-treatment-seeking individuals with Alcohol Use Disorder (AUD) (N=40, 50% female) randomized to IN insulin or placebo. In a bar laboratory setting, randomized participants will receive a single dose of IN insulin (80IU) or an IN matched placebo (0.9% Saline). Participants will undergo a cue-reactivity paradigm followed by an alcohol challenge that includes an alcohol drink designed to raise the breath alcohol content (BrAC) to 0.08g/dL.
The 2 groups in the trial
- Insulin, Then PlaceboTreatment being tested
There will be one single administration of intranasal human insulin (80IU) before alcohol self-administration. After a one week washout period, there will be one single intranasal administration of placebo (saline, 0.9% solution) before alcohol self administration.
Treatment: Regular Human Insulin then Placebo
- Placebo, Then InsulinTreatment being tested
There will be one single intranasal administration of placebo (saline, 0.9% solution) before alcohol self administration. After a one week washout period, there will be one single administration of intranasal human insulin (80IU) before alcohol self-administration.
Treatment: Placebo then Regular Human Insulin
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT05988632, who can take part
- Publications
- Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial.Contemporary clinical trials communications, 2025
- Record updated
- 30 September 2026